J 2003

Chemotherapy with Ifosfamide and concomitant radiotherapy in limited disease (LD) small cell lung cancer (SCLC)

PÁLKOVÁ, Ivana, Jana SKŘIČKOVÁ, Jana KAPLANOVÁ, Lenka BABIČKOVÁ, Olga KUBOVÁ et. al.

Basic information

Original name

Chemotherapy with Ifosfamide and concomitant radiotherapy in limited disease (LD) small cell lung cancer (SCLC)

Authors

PÁLKOVÁ, Ivana (203 Czech Republic), Jana SKŘIČKOVÁ (203 Czech Republic, guarantor), Jana KAPLANOVÁ (203 Czech Republic), Lenka BABIČKOVÁ (203 Czech Republic), Olga KUBOVÁ (203 Czech Republic), Marcela TOMÍŠKOVÁ (203 Czech Republic), Adam SVOBODNÍK (203 Czech Republic) and Jana KOPTÍKOVÁ (203 Czech Republic)

Edition

Lung Cancer, 2003, 0169-5002

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30203 Respiratory systems

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.798

RIV identification code

RIV/00216224:14110/03:00009443

Organization unit

Faculty of Medicine

Keywords in English

Small cell lung cancer; limited disesase; chemotherapy; Ifosfamide
Změněno: 19/1/2004 10:23, prof. MUDr. Jana Skřičková, CSc.

Abstract

V originále

A restrospective study of 115 consecutive pts. with limited SCLC was aimed at therapeutic results and toxicity. From preliminary results authors conclude that the use of IFO/CBDCA/VP16 with concomitant raditherapy is an effective therapy, radiotherapy reducing the treatment time.

Links

MSM 141100003, plan (intention)
Name: Zevní prostředí - karcinogeneze - onkologie
Investor: Ministry of Education, Youth and Sports of the CR, Environment - carcinogenesis - oncology